Patents Assigned to Shanghai Argo Biopharmaceutical Co., Ltd.
  • COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION
    Publication number: 20240084304
    Abstract: Provided are a composition and method for inhibiting angiotensinogen (AGT) protein expression. Specifically, provided are a composition and method capable of being used for reducing AGT gene expression and treating AGT-related diseases and disorders. Provided are an AGT dsRNA reagent capable of being used for reducing AGT expression in a cell and an object, an AGT antisense polynucleotide reagent, a composition containing the AGT dsRNA reagent, and a composition containing the AGT antisense polynucleotide reagent.
    Type: Application
    Filed: September 25, 2023
    Publication date: March 14, 2024
    Applicant: Shanghai Argo Biopharmaceutical Co., Ltd.
    Inventors: Dongxu Shu, Pengcheng Patrick Shao